Market capitalization | $8.70b |
Enterprise Value | $10.32b |
P/E (TTM) P/E ratio | 37.25 |
EV/FCF (TTM) EV/FCF | 22.94 |
EV/Sales (TTM) EV/Sales | 3.41 |
P/S ratio (TTM) P/S ratio | 2.88 |
P/B ratio (TTM) P/B ratio | 1.94 |
Dividend yield | 0.73% |
Last dividend (FY24) | $1.36 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
16 Analysts have issued a Teleflex Incorporated forecast:
16 Analysts have issued a Teleflex Incorporated forecast:
Sep '24 |
+/-
%
|
||
Revenue | 3,026 3,026 |
2%
2%
|
|
Gross Profit | 1,690 1,690 |
3%
3%
|
|
EBITDA | 814 814 |
0%
0%
|
EBIT (Operating Income) EBIT | 547 547 |
4%
4%
|
Net Profit | 237 237 |
41%
41%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.
Head office | United States |
CEO | Liam Kelly |
Employees | 14,500 |
Founded | 1943 |
Website | www.teleflex.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.